These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 13396925)

  • 1. Comparison in man of adrenergic blockade produced by Dibenzyline, Ilidar, Priscoline, and Regitine.
    GREEN HD
    Circulation; 1957 Jan; 15(1):47-53. PubMed ID: 13396925
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the potency of dibenzyline, ilidar, phentolamine (regitine) and tolazoline (priscoline) in blocking the vasoconstrictor responses in canine muscle to lumbar sympathetic stimulation and to intra-arterial injections of L-epinephrine and of L-norepinephrine.
    GREEN HD; DENISON AB; WILLIAMS WO; GARVEY AH; TABOR CG
    J Pharmacol Exp Ther; 1954 Dec; 112(4):462-72. PubMed ID: 13222239
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of adrenergic blocking action of ilidar (Ro 2-3248), regitine (C-7337) and priscoline in the innervated saphenous arterial bed (skin exclusive of muscle) and femoral arterial bed (muscle exclusive of skin) of the anesthetized dog.
    JOHNSON HD; GREEN HD; LANIER JT
    J Pharmacol Exp Ther; 1953 Jun; 108(2):144-57. PubMed ID: 13062085
    [No Abstract]   [Full Text] [Related]  

  • 4. An evaluation of the ability of priscoline, regitine, and roniacol to overcome vasospasm in normal man; estimation of the probable clinical efficacy of these drugs in vasospastic peripheral vascular disease.
    GREEN HD; GOBEL WK; MOORE MJ; PRINCE TC
    Circulation; 1952 Oct; 6(4):520-8. PubMed ID: 12979064
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trial of ilidar; a new dibenzazepine adrenergic blocking drug, in the treatment of peripheral vascular diseases and miscellaneous complaints.
    GREEN HD; DUBOSE HH
    Circulation; 1954 Sep; 10(3):374-83. PubMed ID: 13190610
    [No Abstract]   [Full Text] [Related]  

  • 6. [EFFECTS OF PHENOXYBENZAMINE, PHENTOLAMINE AND AZAPETINE ON ADRENERGIC SYNAPSES OF THE CAT SPLEEN. BLOCKADE OF ALPHA-ADRENERGIC RECEPTORS AND INHIBITION OF RE-UPTAKE OF NEURALLY RELEASED NORADRENALINE].
    THOENEN H; HUERLIMANN A; HAEFELY W
    Helv Physiol Pharmacol Acta; 1964; 22():148-61. PubMed ID: 14246442
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical effects of azapetine (ilidar) on peripheral arterial disease.
    STALLWORTH JM; JEFFORDS JV
    J Am Med Assoc; 1956 Jun; 161(9):840-3. PubMed ID: 13319017
    [No Abstract]   [Full Text] [Related]  

  • 8. THE ADRENERGIC RECEPTIVE MECHANISM OF THE RAT UTERUS.
    LEVY B; TOZZI S
    J Pharmacol Exp Ther; 1963 Nov; 142():178-84. PubMed ID: 14079654
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical appraisal of intra-arterial priscoline therapy in the management of peripheral arterial diseases.
    PRANDONI AG; MOSER M
    Circulation; 1954 Jan; 9(1):73-81. PubMed ID: 13116379
    [No Abstract]   [Full Text] [Related]  

  • 10. DRUGS FOR PERIPHERAL VASCULAR DISEASE.
    FRIEND DG
    Clin Pharmacol Ther; 1964; 5():666-72. PubMed ID: 14209779
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of regitine (C-7337) in patients, particularly those with peripheral arterial vascular disease.
    GREEN HD; GRIMSLEY WT
    Circulation; 1953 Apr; 7(4):487-96. PubMed ID: 13033075
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the blockade produced by dibenzyline, ilidar, tolazoline and phentolamine of the vasomotor responses in skin induced by sympathetic nerve stimulation with the blockade of its responses to L-epinephrine and L-norepinephrine.
    GREEN HD; MACLEOD JA; ANDERSON DA; DENISON AB
    J Pharmacol Exp Ther; 1954 Oct; 112(2):218-30. PubMed ID: 13212632
    [No Abstract]   [Full Text] [Related]  

  • 13. THE ADRENERGIC MECHANISM.
    CRANDELL DL
    Clin Anesth; 1963; 2():35-52. PubMed ID: 14066274
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical appraisal of a new adrenergic blocking agent: effect of regitine on digital blood flow in normal subjects and patients with peripheral arterial diseases.
    CLARKE CW; HAYS DR; VAN ITALLIE TB
    Circulation; 1953 Nov; 8(5):715-22. PubMed ID: 13106893
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical applications of adrenergic blockade in vascular diseases with special reference to dibenamine and 688A.
    HAIMOVICI H
    Angiology; 1951 Dec; 2(6):531-54. PubMed ID: 14894859
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of vasospastic diseases of the extremities by dibenzyline: preliminary report].
    HERRMANN O; ARMAS CRUZ R
    Rev Med Chil; 1954 Jul; 82(7):413-7. PubMed ID: 13225102
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of priscoline on the clearance of radiosodium from muscle and skin of man in normal and diseased limbs.
    FREUND J; WISHAM LH; YALOW RS
    Circulation; 1953 Jul; 8(1):89-97. PubMed ID: 13059867
    [No Abstract]   [Full Text] [Related]  

  • 18. DRUGS USED IN PERIPHERAL VASCULAR DISEASES.
    ABRAMSON DI
    Am J Cardiol; 1963 Aug; 12():203-15. PubMed ID: 14054104
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment of peripheral blood circulation disorders with ilidar].
    SIEGENTHALER P
    Schweiz Med Wochenschr; 1959 Apr; 89():460-2. PubMed ID: 14446485
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with the intravenous administration of ilidar in organic arterial occlusion of the extremities].
    HERRMANN O
    Ther Umsch; 1959 Sep; 16():300-4. PubMed ID: 14401371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.